Member states contact points for translations review
Submitted by Anonymous (not verified) on 25 March 2026 - 8:26
Member states contact points for translations review
2025 European Medicines Agency annual report on independence
Submitted by Anonymous (not verified) on 25 March 2026 - 8:20
2025 European Medicines Agency annual report on independence
List of medicines under additional monitoring
Submitted by Anonymous (not verified) on 25 March 2026 - 8:19
List of medicines under additional monitoring
List of medicinal products under additional monitoring
Submitted by Anonymous (not verified) on 25 March 2026 - 8:18
List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
Submitted by Anonymous (not verified) on 25 March 2026 - 8:18
List of medicinal products under additional monitoring
Mobile scanning and other technologies in the labelling and/or package leaflet of centrally authorised medicinal products
Submitted by Anonymous (not verified) on 25 March 2026 - 8:12
Mobile scanning and other technologies in the labelling and/or package leaflet of centrally authorised medicinal products
Request/declaration form for the provision of information via mobile scanning and other technologies in the centralised procedure
Submitted by Anonymous (not verified) on 25 March 2026 - 8:11
Request/declaration form for the provision of information via mobile scanning and other technologies in the centralised procedure
Human medicines European public assessment report (EPAR): Sylvant, siltuximab, Date of authorisation: 22/05/2014, Revision: 15, Status: Authorised
Submitted by Anonymous (not verified) on 24 March 2026 - 16:35
Human medicines European public assessment report (EPAR): Sylvant, siltuximab, Date of authorisation: 22/05/2014, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Stivarga, regorafenib, Date of authorisation: 26/08/2013, Revision: 24, Status: Authorised
Submitted by Anonymous (not verified) on 24 March 2026 - 16:30
Human medicines European public assessment report (EPAR): Stivarga, regorafenib, Date of authorisation: 26/08/2013, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Kanuma, sebelipase alfa, Date of authorisation: 28/08/2015, Revision: 11, Status: Authorised
Submitted by Anonymous (not verified) on 24 March 2026 - 16:18
Human medicines European public assessment report (EPAR): Kanuma, sebelipase alfa, Date of authorisation: 28/08/2015, Revision: 11, Status: Authorised